Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population

Moderate to severe psoriasis often requires treatment with systemic agents, many of which have immunosuppressive properties and could increase cancer risk, including nonmelanoma skin cancer (NMSC).

http://ift.tt/2k1dzhl